跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TACROLIMUS SANDOZ PROLONGED RELEASE CAPSULES 5MG - PPB Drug Approval Details
Approvals
/
PPB
/
TACROLIMUS SANDOZ PROLONGED RELEASE CAPSULES 5MG
Approved
STANDARD
TACROLIMUS SANDOZ PROLONGED RELEASE CAPSULES 5MG
SANDOZ HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
b71f7a12af7d56a9
Company
SANDOZ HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
b71f7a12af7d56a9
Product Name
TACROLIMUS SANDOZ PROLONGED RELEASE CAPSULES 5MG
Drug Hk Name
TACROLIMUS SANDOZ PROLONGED RELEASE CAPSULES 5MG
Registration Code
HK-67017
Company Name
SANDOZ HONG KONG LIMITED
Company Detail Path
/organization/sandoz-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2021-03-09
Company Address
UNIT 2901, NO. 28 STANLEY STREET, CENTRAL, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
b71f7a12af7d56a9
Type
Standard
Back to PPB Approvals
